Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myeloma

International Journal of Hematology

Volumn 93, Issue 6, 2011, Pages 791-794

  Schmitt, Stefan ^a   Goldschmidt, H ^a   Storch Hagenlocher, B ^a   Pham, M ^a   Fingerle Rowson, G ^b   Ho, A D ^a   Neben, K ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JANSSEN CILAG GMBH   (Germany)

Author keywords

Autoimmune neuropathy; Bortezomib; Multiple myeloma; Polyvalent immunoglobulins; Proteasome inhibitor

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; BORTEZOMIB; DEXAMETHASONE; DOXORUBICIN; GABAPENTIN; IMMUNOGLOBULIN;

AGED; ARTICLE; BLOOD BRAIN BARRIER; BRACHIAL PLEXUS NEUROPATHY; CASE REPORT; CERVICAL SPINE; DELTOID MUSCLE; ELECTROMYOGRAPHY; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HUMAN; INFLAMMATORY AUTOIMMUNE NEUROPATHY; ISOELECTRIC FOCUSING; LABORATORY TEST; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; MUSCLE DENERVATION; NERVE CONDUCTION; NERVE PLEXUS; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; SENSORY NEUROPATHY; SHOULDER PAIN; TIBIALIS ANTERIOR MUSCLE; TRANSCRANIAL MAGNETIC STIMULATION; TRICEPS BRACHII MUSCLE;

AGED; ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; BORONIC ACIDS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PERIPHERAL NERVOUS SYSTEM DISEASES; PYRAZINES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 79960085672     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0847-2     Document Type: Article

References (9)

1. JF San Miguel R Schlag NK Khuageva 2008 Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma N Engl J Med 359 906 917
2. PG Richardson W Xie C Mitsiades 2009 Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy J Clin Oncol 27 3518 3525
3. PG Richardson P Sonneveld MW Schuster 2009 Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline Br J Haematol 144 895 903
4. B Mohty J El-Cheikh I Yakoub-Agha P Moreau JL Harousseau M Mohty 2010 Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations Haematologica 95 311 319
5. AA Argyriou G Iconomou HP Kalofonos 2008 Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature Blood 112 1593 1599
6. A Broyl SL Corthals JL Jongen 2010 Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial Lancet Oncol 11 1057 1065
7. R Hughes 2008 The role of IVIg in autoimmune neuropathies: the latest evidence J Neurol 255 7 11
8. Teoh G, Tan D, Hwang W, Koh LP, Chuah C, Ng HJ. Use of immunoglobulin infusions in the management of bortezomib induced peripheral neuropathy in multiple myeloma. Blood (ASH Annual Meeting Abstracts). 2006;108. Abstract 5097.
9. S Ravaglia A Corso G Piccolo 2008 Immune-mediated neuropathies in myeloma patients treated with bortezomib Clin Neurophysiol 119 2507 2512